it remains a tough year for biotech stocks while the sp 500 is up 25 so far in 2021 key biotech exchangetraded funds are lagging behind dramatically the ishares biotechnology etf ticker ibb which is weighted toward larger biotech names is up 13 in 2021 while the spdr sp biotech etf xbi which is spread more evenly across smaller and midcap biotech names is down 122